Biotechnology Stocks Under the Scanner — PTC Therapeutics, Inovio Pharma, VIVUS, and Spectrum Pharma

How These Retail REIT’s Stocks are Performing? – Brixmor Property, Macerich, Tanger Factory Outlet Centers, and Kite Realty
July 7, 2016
Industrial Goods Sector Equities Coverage — Emerson Electric, Illinois Tool Works, AO Smith, and Interface
July 11, 2016

Biotechnology Stocks Under the Scanner — PTC Therapeutics, Inovio Pharma, VIVUS, and Spectrum Pharma

On Friday, July 08, 2016, the NASDAQ Composite ended the trading session at 4,956.76, up 1.64%; the Dow Jones Industrial Average advanced 1.40%, to finish at 18,146.74; and the S&P 500 closed at 2,129.90, up 1.53%. The gains were broad based as all the sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: PTC Therapeutics Inc. (NASDAQ: PTCT), Inovio Pharmaceuticals Inc. (NASDAQ: INO), VIVUS Inc. (NASDAQ: VVUS), and Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI).

 

South Plainfield, New Jersey headquartered biopharmaceutical company, PTC Therapeutics Inc.’s stock finished Friday’s session 0.27% higher at $7.53 with a total volume of 781,974 shares traded. The Company’s shares have gained 18.21% in the past three months. The stock is trading above its 50-day moving average by 2.59%. PTC Therapeutics’ stock has a Relative Strength Index (RSI) of 54.88.

 

Plymouth Meeting, Pennsylvania headquartered clinical stage biopharmaceutical company, Inovio Pharmaceuticals Inc.’s stock edged 0.33% higher to close the day at $9.11 with a total volume of 1.44 million shares traded. The Company’s shares have gained 25.31% in the previous one year. The stock is trading 17.75% above its 200-day moving average. Additionally, Inovio Pharmaceuticals’ stock has an RSI of 42.13.

 

On Friday, shares in VIVUS Inc. a biopharmaceutical company, which develops and commercializes therapies to address unmet medical needs in the United States and the European Union, ended the day 1.72% higher at $1.18 with a total volume of 130,010 shares traded. The stock is trading below its 50-day moving average by 5.08%. Furthermore, shares of VIVUS have an RSI of 50.14.

 

On Friday, shares in biotechnology company, Spectrum Pharmaceuticals Inc., ended the session 0.59% lower at $6.75 with a total volume of 686,689 shares traded. The stock is trading 12.15% above its 200-day moving average. Moreover, shares of Spectrum Pharmaceuticals have an RSI of 44.88. The Company was founded in 1987 and is headquartered in Henderson, Nevada.

Disclaimer

Leave a Reply

Your email address will not be published. Required fields are marked *